Rankings
▼
Calendar
BBLG Q3 2016 Earnings — Bone Biologics Corporation Revenue & Financial Results | Market Cap Arena
BBLG
Bone Biologics Corporation
$2M
Q3 2016 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$4M
Net Income
-$4M
EPS (Diluted)
$-660.00
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$2M
Free Cash Flow
-$2M
Stock-Based Comp.
$999,668
Balance Sheet
Total Assets
$1M
Total Liabilities
$8M
Stockholders' Equity
-$7M
Cash & Equivalents
$688,233
← FY 2016
All Quarters
Q4 2016 →
